Levonantradol is discontinued (DEA controlled substance). It is a synthetic cannabinoid analogue of dronabinol (Marinol). It exhibits antiemetic and analgesic effects via activation of CB1 and CB2 cannabinoid receptors. References: Sheshenev AE, Boltukhina EV, Hii KK. Levonantradol: asymmetric synthesis and structural analysis. Chem Commun (Camb). 2013 May 7;49(35):3685-7. doi: 10.1039/c3cc41388h. Epub 2013 Mar 27. PubMed PMID: 23535893.

纯度：≥98%

CAS：71048-87-8